Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients' preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-posit
| Image |  |
|---|---|
| Description | scientific article published on 06 April 2020 |
| Author/s |
author: Ursula Vehling-Kaiser |
| Publication date | April 6, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |